Genome Editing
Platinum TALEN and TALE-ND1
Platinum TALEN and TALE-ND1 have a clear and well-consolidated licensing position, making it well suited to industrial applications. It also delivers high genome editing efficiency with a low risk of off-target mutations.
A further advantage is the high degree of certainty that, when delivered in protein form, no exogenous nucleic acid remains — placing the product outside the scope of the Cartagena Act (i.e., it does not constitute a living modified organism). (Please check the regulations regarding the handling of genome-edited organisms.)
Process
Inquiry — Please begin by contacting us.
Design & Construction — We design and construct the optimal Platinum TALEN and TALE-ND1 for your specified target gene. Target gene identification is also available as an option.
Cleavage Activity Evaluation — We construct a vector for activity assessment and introduce it into cells together with the Platinum TALEN or TALE-ND1 to evaluate cleavage activity.
About Our Plans
Delivery in protein form is also available. Please contact us if this is of interest.
For research applications, we offer plans that additionally permit the provision of genome-edited materials to collaborating partners, continued use, and application to drug screening. Please contact us to discuss your requirements.
Use for purposes other than research is not permitted. Commercial use requires a separate license agreement; please contact us if you are considering such use.